The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice
The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Abstract
To test whether the hypothesis that the Alzheimer's A beta peptide is neurotoxic, we introduced a transgene into mice to direct expression of this peptide to neurons. We show that the transgene is expressed in brain regions which are severely affected in Alzheimer's disease resulting in extensive neuronal degeneration. Morphological and biochemical evidence indicates that the eventual death of these cells occurs by apoptosis. Coincident with the cell degeneration and cell death is the presence of a striking reactive gliosis. Over 50% of the transgenic mice die by 12 months of age, half the normal life span of control mice. These data show that A beta is neurotoxic in vivo and suggest that apoptosis may be responsible for the accompanying neuronal loss, the principal underlying cellular feature of Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While evidence for extracellular Aβ deposition was scarce, neuronal Aβ immunoreactivity was detected in the cortex and hippocampus, resulting in abundant neurodegeneration, with biochemical and morphological evidence for an apoptotic mechanism [61].”
From Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models (2020) · cites this paper as [61]
In the citing paper
“Efficient secretion of Aβ from the BRI fusion protein distinguishes this approach from studies using Aβ minigene constructs that generate high levels of intracellular Aβ and minimal secreted Aβ (LaFerla et al., 1995).”
From Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice (2005) · cites this paper as LaFerla et al., 1995
In the citing paper
“However, none of these studies prove or disprove a role of intracellular Aβ in AD pathogenesis.”
From Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice (2005) · cites this paper as LaFerla et al., 1995
In the citing paper
“Previous studies with transgenic mice expressing Aβ minigenes that are not efficiently secreted suggest that intracellular Aβ can be neurotoxic (LaFerla et al., 1995), as do studies of direct injection of aggregated Aβ into cultured primary neurons (Zhang et al., 2002).”
From Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice (2005) · cites this paper as LaFerla et al., 1995
In the citing paper
“lack of plaque formation in intraneuronal Aβ42 accumulating transgenic mice with concomitant neurodegeneration [36, 93] limited conclusions that could be drawn to the human disease, since pathological diagnosis of AD requires Aβ plaques.”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [93]
Citations
Cites
1 retracted
Kawabata, S., Higgins, G. A., & Gordon, J. W. (1991) · Nature · doi:10.1038/354476a0 · Cited by 108
RetractedIdentification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Kozak, M. (1986) · Cell · doi:10.1016/0092-8674(86)90762-2 · Cited by 4,741
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757
Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) · Nature · doi:10.1038/359325a0 · Cited by 1,731
Production of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing
Shoji, M., Golde, T. E., Ghiso, J., Cheung, T. T., Estus, S., Shaffer, L. M., Cai, X.-D., McKay, D. M., Tintner, R., Frangione, B., et al. (1992) · Science · doi:10.1126/science.1439760 · Cited by 1,447
Research works printed but not linked: 2
- Wyllie, A.H. Cell death. Int. Rev. Cytol. S17, 755–785 (1987).
- Kim, K.S. et al. Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci. Res. Comm. 2, 121–130 (1988).
Cited by
Items 201–300 of 511
Siwek, M. E., Müller, R., Henseler, C., Trog, A., Lundt, A., Wormuth, C., Broich, K., Ehninger, D., Weiergräber, M., & Papazoglou, A. (2015) · Neural Plasticity · doi:10.1155/2015/781731 · Cited by 71
Isoprenoids and Alzheimer's disease: A complex relationship
Cole, S. L., & Vassar, R. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.11.007 · Cited by 71
Moechars, D., Lorent, K., & Leuven, F. V. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00599-5 · Cited by 78
Vyas, S., Javoy-Agid, F., Herrero, M. T., Strada, O., Boissière‐Michot, F., Hibner, U., & Agid, Y. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010223.x · Cited by 70
Aβ deposition inhibitor screen using synthetic amyloid
Esler, W. P., Stimson, E. R., Ghilardi, J. R., Felix, A. M., Lu, Y., Vinters, H. V., Mantyh, P. W., & Maggio, J. E. (1997) · Nature Biotechnology · doi:10.1038/nbt0397-258 · Cited by 85
Rab5 Mediates an Amyloid Precursor Protein Signaling Pathway That Leads to Apoptosis
Laifenfeld, D., Patzek, L. J., McPhie, D. L., Chen, Y., Levites, Y., Cataldo, A. M., & Neve, R. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4599-06.2007 · Cited by 68
Barkats, M., Millecamps, S., Abrioux, P., Geoffroy, M., & Mallet, J. J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751438.x · Cited by 75
The biological role of the Alzheimer amyloid precursor protein in epithelial cells
Schmitz, A., Tikkanen, R., Kirfel, G., & Herzog, V. (2001) · Histochemistry and Cell Biology · doi:10.1007/s00418-001-0351-5 · Cited by 74
Lawlor, P. A., Bland, R. J., Das, P., Price, R. W., Holloway, V., Smithson, L., Dicker, B. L., During, M. J., Young, D., & Golde, T. E. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-11 · Cited by 67
“Use of BRI-Aβ fusions results in enhanced Aβ secretion in the absence of APP overexpression, and distinguishes this approach from overexpression of Aβ minigenes, a strategy that generates high levels of intracellular Aβ but minimal secreted Aβ [30].”
BackgroundProgress toward valid transgenic mouse models for Alzheimer’s disease
Guénette, S. Y., & Tanzi, R. E. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00042-1 · Cited by 74
Suhara, T., Magrané, J., Rosen, K., Christensen, R., Kim, H.-S., Zheng, B., McPhie, D. L., Walsh, K., & Querfurth, H. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00135-5 · Cited by 70
Differential Susceptibility of Brain Areas to Cyanide Involves Different Modes of Cell Death
Mills, E., Gunasekar, P. G., Li, L., Borowitz, J. L., & Isom, G. E. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8630 · Cited by 65
Antibody-Based Drugs and Approaches Against Amyloid-β Species for Alzheimer’s Disease Immunotherapy
Liu, J., Yang, B., Ke, J., Li, W., & Suen, W.-C. (2016) · Drugs & Aging · doi:10.1007/s40266-016-0406-x · Cited by 74
Understanding the molecular basis of Alzheimer’s disease using a Caenorhabditis elegans model system
Ewald, C. Y., & Li, C. (2009) · Brain Structure and Function · doi:10.1007/s00429-009-0235-3 · Cited by 71
Transgenic animals relevant to Alzheimer’s disease
Seabrook, G. R., & Rosahl, T. W. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00170-1 · Cited by 69
Expression of mutant amyloid precursor proteins induces apoptosis in PC12 cells
Zhao, B., Chrest, F. J., Horton, W. E., Sisodia, S. S., & Kusiak, J. W. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19970201)47:3<233::aid-jnr1>3.0.co;2-j · Cited by 65
Kajkowski, E. M., Lo, C. F., Ning, X., Walker, S., Sofia, H. J., Wang, W., Edris, W., Chanda, P., Wagner, E., Vile, S., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011161200 · Cited by 63
Amyloid and lipids in the pathology of Alzheimer disease
Roher, A. E., Kuo, Y.-M., Kokjohn, K. M., Emmerling, M. R., & Gracon, S. (1999) · Amyloid · doi:10.3109/13506129909007315 · Cited by 63
APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD)
Lalonde, R., Fukuchi, K., & Strazielle, C. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.02.011 · Cited by 62
Song, Y. S., Park, H. J., Kim, S. Y., Lee, S. H., Yoo, H. S., Lee, H. S., Lee, M. K., Oh, K. W., Kang, S.-K., Lee, S. E., et al. (2004) · Neuroscience Research · doi:10.1016/j.neures.2004.01.010 · Cited by 62
B�ckig, A., Tikkanen, R., Herzog, V., & Schmitz, A. (2002) · Histochemistry and Cell Biology · doi:10.1007/s00418-002-0459-2 · Cited by 67
Regional hypometabolism in the 3xTg mouse model of Alzheimer's disease
Adlimoghaddam, A., Snow, W. M., Stortz, G., Perez, C., Djordjevic, J., Goertzen, A. L., Ko, J. H., & Albensi, B. C. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.03.008 · Cited by 60
Biological roles of APP in the epidermis
Herzog, V., Kirfel, G., Siemes, C., & Schmitz, A. (2004) · European Journal of Cell Biology · doi:10.1078/0171-9335-00401 · Cited by 69
Activation of Phospholipase A2 by Amyloid β-Peptides in Vitro
Lehtonen, J. Y. A., Holopainen, J. M., & Kinnunen, P. K. J. (1996) · Biochemistry · doi:10.1021/bi960148o · Cited by 61
Torp, R., Head, E., Milgram, N. W., Hahn, F. F., Ottersen, O. P., & Cotman, C. W. (2000) · Neuroscience · doi:10.1016/s0306-4522(99)00568-0 · Cited by 68
Significance of intracellular Ab42 accumulation in alzheimer's disease
Tabira, T. (2002) · Frontiers in Bioscience · doi:10.2741/tabira · Cited by 59
de la Monte, S. M., Lu, B.-X., Sohn, Y. K., ETIENNE, D., Kraft, J., Ganju, N., & Wands, J. R. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00108-6 · Cited by 62
Lesuis, S. L., Maurin, H., Borghgraef, P., Lucassen, P. J., Leuven, F. V., & Krugers, H. J. (2016) · Oncotarget · doi:10.18632/oncotarget.9776 · Cited by 58
Yin, D.-L., Ren, X., Zheng, Z.-L., Pu, L., Jiang, L., Ma, L., & Pei, G. (1997) · Neuroscience Research · doi:10.1016/s0168-0102(97)00080-1 · Cited by 61
London, J. A., Biegel, D., & Pachter, J. S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4147 · Cited by 58
Apoptosis, Neurotrophic Factors and Neurodegeneration
Dragunow, M., MacGibbon, G. A., Lawlor, P. A., Butterworth, N. J., Connor, B. J., Henderson, C. E., Walton, M. R., Woodgate, A.-M., Hughes, P. E., & Faull, R. L. M. (1997) · Reviews in the Neurosciences · doi:10.1515/revneuro.1997.8.3-4.223 · Cited by 65
Saha, P., Guha, S., & Biswas, S. C. (2020) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2020.103551 · Cited by 61
Zhao, L., Mao, Z., Chen, S., Schneider, L. S., & Brinton, R. D. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-122341 · Cited by 57
Ghahremanitamadon, F., Shahidi, ., Zargooshnia, S., Nikkhah, A., Ranjbar, A., & Asl, S. S. (2014) · BioMed Research International · doi:10.1155/2014/798535 · Cited by 65
Zhang, W., Gu, G., Zhang, Q., Liu, J., Zhang, B., Guo, Y. C., Wang, M., Gong, Q., & Xu, J. (2017) · Hippocampus · doi:10.1002/hipo.22794 · Cited by 61
Neurologic and motor dysfunctions in APP transgenic mice
Lalonde, R., Fukuchi, K.-I., & Strazielle, C. (2012) · Reviews in the Neurosciences · doi:10.1515/revneuro-2012-0041 · Cited by 64
Aberrant expression of bcl-2 gene family in Down's syndrome brains
Sawa, A., Oyama, F., Cairns, N. J., Amano, N., & Matsushita, M. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00078-8 · Cited by 61
Leschik, J., Welzel, A., Weissmann, C., Eckert, A., & Brandt, R. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04435.x · Cited by 56
Genetics of Early-Onset Alzheimer Dementia
Rademakers, R., Cruts, M., & Van Broeckhoven, C. (2003) · The Scientific World JOURNAL · doi:10.1100/tsw.2003.39 · Cited by 57
Cribbs, D. H., Chen, L.-S., Bende, S. M., & LaFerla, F. M. (1996) · Europe PMC (PubMed Central) · Cited by 57
Self-citationKawasumi, M., Hashimoto, Y., Chiba, T., Kanekura, K., Yamagishi, Y., Ishizaka, M., Tajima, H., Niikura, T., & Nishimoto, I. (2002) · Neurosignals · doi:10.1159/000067424 · Cited by 54
Mbebi, C., Sée, V., Mercken, L., Pradier, L., Müller, U., & Loeffler, J.-P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107948200 · Cited by 54
Aoki, M., Volkmann, I., Tjernberg, L. O., Winblad, B., & Bogdanovic, N. (2008) · NeuroReport · doi:10.1097/wnr.0b013e328302c858 · Cited by 53
BAD-mediated neuronal apoptosis and neuroinflammation contribute to Alzheimer's disease pathology
Zhang, L., Qian, Y., Li, J., Zhou, X., Xu, H. J., Yan, J., Xiang, J., Yuan, X., Sun, B., Sisodia, S. S., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102942 · Cited by 57
Mouse Models of Alzheimer's Disease: A Quest for Plaques
Richardson, J. A., & Burns, D. K. (2002) · ILAR Journal · doi:10.1093/ilar.43.2.89 · Cited by 53
Sugaya, K., Reeves, M., & McKinney, M. (1997) · Neurochemistry International · doi:10.1016/s0197-0186(96)00158-1 · Cited by 53
The β-Amyloid Precursor Protein and its Derivatives: From Biology to Learning and Memory Processes
Dodart, J.-C., Mathis, C., & Ungerer, A. (2000) · Reviews in the Neurosciences · doi:10.1515/revneuro.2000.11.2-3.75 · Cited by 52
Fraser, A. G., McCarthy, N., & Evan, G. I. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80011-0 · Cited by 61
Brain Amyloid — A Physicochemical Perspective
Maggie, J. E., & Mantyh, P. W. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00797.x · Cited by 53
Amyloid in Alzheimer's disease and prion-related encephalopathies: studies with synthetic peptides
Forloni, G., Tagliavini, F., Bugiani, O., & Salmona, M. (1996) · Progress in Neurobiology · doi:10.1016/0301-0082(96)00013-5 · Cited by 53
Drosophila Amyloid Precursor Protein-Like Is Required for Long-Term Memory
Goguel, V., Belair, A.-L., Ayaz, D., Lampin-Saint-Amaux, A., Scaplehorn, N., Hassan, B. A., & Preat, T. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2896-10.2011 · Cited by 49
Wang, H.-Y., Bakshi, K. P., Shen, C., Frankfurt, M., Trocmé, C., & Morain, P. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.031 · Cited by 55
Novel insights into RIPK1 as a promising target for future Alzheimer’s disease treatment
Li, S., Qu, L., Wang, X., & Kong, L. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107979 · Cited by 52
Transgenic mice expressing APP-C100 in the brain.
Neve, R. L., Boyce, F. M., McPhie, D. L., Greenan, J., & Oster-Granite, M. L. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(95)02074-8 · Cited by 46
Czech, C., Lesort, M. J., Tremp, G. L., Terro, F., Blanchard, V., Schombert, B., Carpentier, N., Dreisler, S., Bonici, B., Takashima, A., et al. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00162-6 · Cited by 51
Interleukin-3 prevents neuronal death induced by amyloid peptide
Zambrano, A., Otth, C., Mujica, L., Concha, I. I., & Maccioni, R. B. (2007) · BMC Neuroscience · doi:10.1186/1471-2202-8-82 · Cited by 47
Attia, H., Albuhayri, S., Alaraidh, S., Alotaibi, A., Yacoub, H. I., Mohamad, R. A., & Alamin, M. A. (2020) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22519 · Cited by 50
Dewhurst, S., Gelbard, H. A., & Fine, S. M. (1996) · Molecular Medicine Today · doi:10.1016/1357-4310(96)88754-5 · Cited by 48
Targeting STAT3: A crucial modulator of sepsis
Lei, W., Liu, D., Sun, M., Lu, C., Yang, W., Wang, C., Cheng, Y., Zhang, M., Shen, M., Yang, Z. P., et al. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30394 · Cited by 48
Greenberg, B., Savage, M. J., Howland, D., Ali, S. M., Siedlak, S. L., Perry, G. L., Siman, R., & Scott, R. W. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00001-2 · Cited by 47
Sudol, K. L., Mastrangelo, M. A., Narrow, W. C., Frazer, M. E., Levites, Y. R., Golde, T. E., Federoff, H. J., & Bowers, W. J. (2009) · Molecular Therapy · doi:10.1038/mt.2009.174 · Cited by 44
Innate Immunity and Cell Death in Alzheimer’s Disease
Lee, S., Cho, H.-J., & Ryu, J.-H. (2021) · ASN Neuro · doi:10.1177/17590914211051908 · Cited by 45
Stereochemical specificity of Alzheimer's disease ?-peptide assembly
Esler, W. P., Stimson, E. R., Fishman, J. B., Ghilardi, J. R., Vinters, H. V., Mantyh, P. W., & Maggio, J. E. (1999) · Biopolymers · doi:10.1002/(sici)1097-0282(199905)49:6<505::aid-bip8>3.0.co;2-i · Cited by 51
Mark, M. D., & Storm, D. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.27.17238 · Cited by 45
β-Amyloid(1-40)-induced neurodegeneration in the rat hippocampal neurons of the CA1 subfield
Miguel-Hidalgo, J. J., & Cacabelos, R. (1998) · Acta Neuropathologica · doi:10.1007/s004010050825 · Cited by 48
Neuroprotective effect of interleukin-6 in a rat model of cerebral ischemia
Feng, Q., WANG, Y., & Ying-da, Y. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2363 · Cited by 44
Ling, D., Magallanes, M., & Salvaterra, P. M. (2014) · ASN Neuro · doi:10.1042/an20130044 · Cited by 44
Saha, P., & Biswas, S. C. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.08.002 · Cited by 43
Tajes, M., Eraso‐Pichot, A., Rubio-Moscardó, F., Guivernau, B., Ramos‐Fernández, E., Bosch-Morató, M., Guix, F. X., Clarimón, J., Miscione, G. P., Boada, M., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131685 · Cited by 48
Saillé, C., Marin, P., Martinou, J., Nicole, A., London, J., & Ceballos-Picot, I. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00089-5 · Cited by 48
Engineered antibody approaches for Alzheimer’s disease immunotherapy
Robert, R., & Wark, K. L. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.02.022 · Cited by 45
Lewis, P. A., Piper, S., Baker, M., Onstead, L., Murphy, M. P., Hardy, J., Wang, R., McGowan, E., & Golde, T. E. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(01)00054-0 · Cited by 38
The βA4 Amyloid Precursor Protein Gene and Alzheimer's Disease
Hendriks, L., & Broeckhoven, C. V. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0006n.x · Cited by 45
Kar, A. N., Lee, S. J., & Twiss, J. L. (2017) · The Neuroscientist · doi:10.1177/1073858417712668 · Cited by 50
Escrig, A., Canal, C., Sanchís, P., Fernández‐Gayol, O., Montilla, A., Comes, G., Molinero, A., Giralt, M., Giménez‐Llort, L., Becker‐Pauly, C., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.08.005 · Cited by 44
Mohamed, A., Saavedra, L., Di Pardo, A., Sipione, S., & Posse de Chaves, E. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0630-12.2012 · Cited by 41
Apoptosis and Bcl-xs in the intimal thickening of balloon-injured carotid arteries
Igase, M., Okura, T., Kitami, Y., & Hiwada, K. (1999) · Clinical Science · doi:10.1042/cs0960605 · Cited by 41
Querfurth, H. W., Suhara, T., Rosen, K. M., McPhie, D. L., Fujio, Y., Tejada, G., Neve, R. L., Adelman, L. S., & Walsh, K. X. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2001.0972 · Cited by 44
Distinct pH homeostatic features in lymphoblasts from Alzheimer's disease patients
Ibarreta, D., Urcelay, E., Parrilla, R., & Ayuso, M. S. (1998) · Annals of Neurology · doi:10.1002/ana.410440212 · Cited by 42
The Effects of Soluble A.β Oligomers on Neurodegeneration in Alzheimer's Disease
Brouillette, J. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990498 · Cited by 42
Okura, T., Igase, M., Kitami, Y., Fukuoka, T., Maguchi, M., Kohara, K., & Hiwada, K. (1998) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(98)00065-2 · Cited by 39
Role of potassium channels in Aβ1–40‐activated apoptotic pathway in cultured cortical neurons
Yu, H., Li, Z., Zhang, H., & Wang, X. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.21054 · Cited by 39
Luo, J. J., Wallace, W., Riccioni, T., Ingram, D. K., Roth, G. S., & Kusiak, J. W. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990301)55:5<600::aid-jnr7>3.0.co;2-# · Cited by 40
Peroxide-scavenging deficit underlies oligodendrocyte susceptibility to oxidative stress
Juurlink, B. H. J., Thorburne, S. K., & Hertz, L. (1998) · Glia · doi:10.1002/(sici)1098-1136(199804)22:4<371::aid-glia6>3.0.co;2-6 · Cited by 196
Dehghan, A., Pinto, R. C., Karaman, İ., Huang, J. V., Durainayagam, B. R., Ghanbari, M., Nazeer, A., Zhong, Q., Liggi, S., Whiley, L., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2206083119 · Cited by 38
Aβ production as consequence of cellular death of a human neuroblastoma overexpressing APP
Recuero, M., Serrano, E., Bullido, M. J., & Valdivieso, F. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.06.025 · Cited by 50
de la Monte, S. M., & Wands, J. R. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.2.195 · Cited by 38
Sawmiller, D., Habib, A., Hou, H., Mori, T., Fan, A., Tian, J., Zeng, J., Giunta, B., Sanberg, P. R., Mattson, M. P., et al. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.04.026 · Cited by 38
RetractedLuetjens, C. M., Lankiewicz, S., Bui, N. T., Krohn, A. J., Poppe, M., & Prehn, J. H. M. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00458-9 · Cited by 41
Genetically altered transgenic models of Alzheimer’s disease
Masliah, E., & Rockenstein, E. M. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6781-6_20 · Cited by 43
Ginkgolide A, B, and huperzine A inhibit nitric oxide-induced neurotoxicity
Zhao, H., & Li, X. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00093-0 · Cited by 36
Roßner, S. (1997) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(97)00035-x · Cited by 38
Effect of N‐homocysteinylation on physicochemical and cytotoxic properties of amyloid β‐peptide
Khodadadi, S., Riazi, G. H., Ahmadian, S., Hoveizi, E., Karima, O., & Aryapour, H. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.12.018 · Cited by 43
Kantar, D., Hidişoğlu, E., Ocak, G. A., Er, H., Acun, A. D., & Yargıçoğlu, P. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.04.008 · Cited by 36
TUNEL staining of inner ear structures may reflect autolysis, not apoptosis
Nishizaki, K., Yoshino, T., Orita, Y., Nomiya, S., & Masuda, Y. (1999) · Hearing Research · doi:10.1016/s0378-5955(99)00002-7 · Cited by 35
Review: PrP 106‐126 – 25 years after
Forloni, G., Chiesa, R., Bugiani, O., Salmona, M., & Tagliavini, F. (2019) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12538 · Cited by 42
Hall, G. F., Lee, S., & Yao, J. (2002) · Journal of Molecular Neuroscience · doi:10.1385/jmn:19:3:251 · Cited by 39
Neurodegeneration in Alzheimer disease: Is apoptosis involved?
Kusiak, J. W., Izzo, J. A., & Zhao, B. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815217 · Cited by 40
Single-Gene Determinants of Epilepsy Comorbidity
Noebels, J. L. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a022756 · Cited by 35
In vivo and in vitro neuroprotective effects of Panax ginseng glycoproteins
Luo, H., Hu, J., Wang, Y., Chen, Y., Zhu, D., Jiang, R., & Qiu, Z. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.02.015 · Cited by 34
Metadata
- Authors
- LaFerla, F. M., Tinkle, B. T., Bieberich, C. J., Haudenschild, C. C., & Jay, G.
- Venue
- Nature Genetics
- Published
- 1995-01
- Volume
- 9
- Issue
- 1
- Pages
- 21-30
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1992484817
- Cited by
- 513
- References
- 69
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 2 · 2022: 7 · 2021: 8 · 2020: 11 · 2019: 12 · 2018: 5 · 2017: 7 · 2016: 11 · 2015: 16 · 2014: 13 · 2013: 9 · 2012: 13
- FWCI
- 34.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, amyloid-beta, neurotoxicity, neuronal apoptosis, neurodegeneration, reactive gliosis, transgenic mice, neuronal loss
- MeSH terms
- Alzheimer Disease, Animals, Base Sequence, Gliosis, Humans, Mice, Transgenic, Molecular Sequence Data, Nerve Degeneration, DNA Probes, Gene Expression, Amyloid beta-Peptides, Apoptosis, In Situ Hybridization, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.